KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Share-based Compensation (2016 - 2025)

Teladoc Health (TDOC) has disclosed Share-based Compensation for 12 consecutive years, with $15.9 million as the latest value for Q4 2025.

  • Quarterly Share-based Compensation fell 42.08% to $15.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $80.4 million through Dec 2025, down 44.9% year-over-year, with the annual reading at $80.4 million for FY2025, 44.9% down from the prior year.
  • Share-based Compensation hit $15.9 million in Q4 2025 for Teladoc Health, down from $17.0 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $86.3 million in Q1 2021 to a low of $15.9 million in Q4 2025.
  • Historically, Share-based Compensation has averaged $47.4 million across 5 years, with a median of $48.8 million in 2022.
  • Biggest YoY gain for Share-based Compensation was 371.2% in 2021; the steepest drop was 85.13% in 2021.
  • Year by year, Share-based Compensation stood at $61.6 million in 2021, then decreased by 17.63% to $50.8 million in 2022, then decreased by 7.75% to $46.8 million in 2023, then plummeted by 41.33% to $27.5 million in 2024, then tumbled by 42.08% to $15.9 million in 2025.
  • Business Quant data shows Share-based Compensation for TDOC at $15.9 million in Q4 2025, $17.0 million in Q3 2025, and $22.3 million in Q2 2025.